AI startup Simile raises $200M at a $2B valuation in Series B round

iconChaincatcher
Share
AI summary iconSummary
AI startup Simile, founded by Stanford PhD Joon Sung Park, has raised $200 million in a Series B round at a $2 billion valuation, just five months after its $100 million Series A. Greenoaks led the round, with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures. CVS is also a major client of Simile, which aims to simulate all 8 billion people on Earth for marketing and product research. As altcoins to watch gain momentum, this move reflects strong investor confidence amid a shifting Fear & Greed Index.

ChainCatcher report, according to TechCrunch, AI startup Simile has raised $200 million in its Series B round at a $2 billion valuation, just five months after completing its $100 million Series A round. The round was led by Greenoaks, with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures. CVS is also Simile’s key client. Simile was founded by Stanford Ph.D. candidate Joon Sung Park, whose doctoral project “Smallville” enables AI agents to simulate human life. The company claims its goal is to “accurately and honestly simulate all 8 billion people on Earth,” using these simulations for marketing and product research.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.